Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Merck’s backing of NGM Bio yields NASH drug deal

Drug has potential in diabetes treatment as well

Eli Lilly HQ

Lilly adds to pharma M&A run with $8bn Loxo buy-out

Lilly claims company ahead of more dominant oncology players

- PMLiVE

BMS and Celgene deal sparks debate on pharma profit motive, more M&A

Biopharma backlash at Warren tweet, but Celgene tactics in the spotlight

Sanofi reception

Sanofi and Regeneron re-jig immuno-oncology deal

Partners refocus around two promising bispecific candidates

Living my best life with multiple sclerosis

Multi-award-winning advocate and patient engagement champion Trishna Bharadia gives a valuable insight into life with multiple sclerosis. She explains how treatment has changed, how our healthcare systems and pharma can...

Blue Latitude Health

- PMLiVE

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Latest movers in pharma and biotech

- PMLiVE

A well-deserved promotion within Porterhouse Medical’s scientific services team

Porterhouse Medical is delighted to announce the promotion of Amanda Hyne to senior medical writer within our scientific services team.2018 has been a tremendous year for Amanda. She has made...

Porterhouse Medical Group

- PMLiVE

Drug pricing is pharma’s top concern in 2019

More than half of industry respondents say pricing will have the greatest negative impact this year

- PMLiVE

AstraZeneca wins NICE backing for asthma injection

NICE hails 'competitive pharma market'

Creative review: ESMO 2018

BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners and giving key insights on how to develop an...

Blue Latitude Health

focus

Focus on doing one thing well

Does pharma have something to learn from Welsh jeans maker Hiut Denim when it comes to focus?

Page & Page Health

Celgene building

BMS and Celgene announce $74bn merger

Huge news for sector, with new fourth-placed company to be created

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links